Sionna Therapeutics, Inc.
SION
$12.04
-$0.10-0.82%
NASDAQ
12/31/2024 | 12/31/2023 | ||||
---|---|---|---|---|---|
Net Income | -15.85M | -11.88M | |||
Total Depreciation and Amortization | 167.00K | 161.00K | |||
Total Amortization of Deferred Charges | -- | -- | |||
Total Other Non-Cash Items | 764.00K | 1.14M | |||
Change in Net Operating Assets | 3.14M | 3.12M | |||
Cash from Operations | -11.78M | -7.45M | |||
Capital Expenditure | -27.00K | -122.00K | |||
Sale of Property, Plant, and Equipment | -- | -- | |||
Cash Acquisitions | -- | -- | |||
Divestitures | -- | -- | |||
Other Investing Activities | 15.26M | 7.25M | |||
Cash from Investing | 15.23M | 7.13M | |||
Total Debt Issued | -- | -- | |||
Total Debt Repaid | -- | -- | |||
Issuance of Common Stock | 25.00K | 0.00 | |||
Repurchase of Common Stock | -- | -- | |||
Issuance of Preferred Stock | 0.00 | -- | |||
Repurchase of Preferred Stock | -- | -- | |||
Total Dividends Paid | -- | -- | |||
Other Financing Activities | -1.43M | -- | |||
Cash from Financing | -1.41M | 0.00 | |||
Foreign Exchange rate Adjustments | -- | -- | |||
Miscellaneous Cash Flow Adjustments | -- | -- | |||
Net Change in Cash | 2.04M | -324.00K | |||